-
1
-
-
0041342015
-
Drug-induced hepatotoxicity
-
Lee W.M. Drug-induced hepatotoxicity. N Engl J Med 349 (2003) 474-485
-
(2003)
N Engl J Med
, vol.349
, pp. 474-485
-
-
Lee, W.M.1
-
2
-
-
0037126649
-
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States
-
Ostapowicz G., Fontana R.J., Schiodt S.V., et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137 (2002) 947-954
-
(2002)
Ann Intern Med
, vol.137
, pp. 947-954
-
-
Ostapowicz, G.1
Fontana, R.J.2
Schiodt, S.V.3
-
3
-
-
42249102412
-
Acute liver failure: summary of a workshop
-
Lee W.M., Squires R.H., Nyberg S.L., et al. Acute liver failure: summary of a workshop. Hepatology 47 (2008) 1401-1415
-
(2008)
Hepatology
, vol.47
, pp. 1401-1415
-
-
Lee, W.M.1
Squires, R.H.2
Nyberg, S.L.3
-
4
-
-
0032522873
-
Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies
-
Lazarou J., Pomeranz B.H., and Corey P.N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279 (1998) 1200-1205
-
(1998)
JAMA
, vol.279
, pp. 1200-1205
-
-
Lazarou, J.1
Pomeranz, B.H.2
Corey, P.N.3
-
5
-
-
0036569927
-
Safety of newly approved drugs
-
Temple R.J., and Himmel M.H. Safety of newly approved drugs. JAMA 287 (2002) 2273-2275
-
(2002)
JAMA
, vol.287
, pp. 2273-2275
-
-
Temple, R.J.1
Himmel, M.H.2
-
6
-
-
0025227871
-
Criteria of drug-induced liver disorders: report of an international consensus meeting
-
Benichou C. Criteria of drug-induced liver disorders: report of an international consensus meeting. J Hepatol 11 (1990) 272-276
-
(1990)
J Hepatol
, vol.11
, pp. 272-276
-
-
Benichou, C.1
-
7
-
-
54449094314
-
Reliability of the Roussel Uclaf Causality Assessment method for assessing causality in drug-induced liver injury
-
Rochon J., Protiva P., Seeff L.B., et al. Reliability of the Roussel Uclaf Causality Assessment method for assessing causality in drug-induced liver injury. Hepatology 48 (2008) 1175-1183
-
(2008)
Hepatology
, vol.48
, pp. 1175-1183
-
-
Rochon, J.1
Protiva, P.2
Seeff, L.B.3
-
8
-
-
13444273562
-
Recognizing drug-induced liver injury: current problems, possible solutions
-
Lee W.M., and Senior J.R. Recognizing drug-induced liver injury: current problems, possible solutions. Toxicol Pathol 33 (2005) 155-164
-
(2005)
Toxicol Pathol
, vol.33
, pp. 155-164
-
-
Lee, W.M.1
Senior, J.R.2
-
9
-
-
57249086242
-
Causes, clinical features and outcomes from a prospective study of drug-induced liver injury in the United States
-
Chalasani N., Fontana R.J., Bonkovsky H.L., et al. Causes, clinical features and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 135 (2008) 1924-1934
-
(2008)
Gastroenterology
, vol.135
, pp. 1924-1934
-
-
Chalasani, N.1
Fontana, R.J.2
Bonkovsky, H.L.3
-
10
-
-
18844373318
-
Role of metabolism in drug-induced idiosyncratic hepatotoxicity
-
Walgren J.L., Mitchell M.D., and Thompson D.C. Role of metabolism in drug-induced idiosyncratic hepatotoxicity. Crit Rev Toxicol 35 (2005) 325-361
-
(2005)
Crit Rev Toxicol
, vol.35
, pp. 325-361
-
-
Walgren, J.L.1
Mitchell, M.D.2
Thompson, D.C.3
-
11
-
-
15444368643
-
Drug-induced hepatotoxicity
-
Maddrey W.C. Drug-induced hepatotoxicity. J Clin Gastroenterol 39 (2005) S83-S89
-
(2005)
J Clin Gastroenterol
, vol.39
-
-
Maddrey, W.C.1
-
12
-
-
34047219944
-
Drug-induced liver injury at an Asian center: a prospective study
-
Wai C.T., Tan B.H., Chan C.L., et al. Drug-induced liver injury at an Asian center: a prospective study. Liver Int 27 (2007) 465-474
-
(2007)
Liver Int
, vol.27
, pp. 465-474
-
-
Wai, C.T.1
Tan, B.H.2
Chan, C.L.3
-
13
-
-
33846056884
-
Antibiotic therapy: a major cause of drug-induced jaundice in southwest England
-
Hussaini S.H., O'Brien C.S., Despott E.J., et al. Antibiotic therapy: a major cause of drug-induced jaundice in southwest England. Eur J Gastroenterol Hepatol 19 (2007) 15-20
-
(2007)
Eur J Gastroenterol Hepatol
, vol.19
, pp. 15-20
-
-
Hussaini, S.H.1
O'Brien, C.S.2
Despott, E.J.3
-
14
-
-
0031026096
-
Role of viral infections in the induction of adverse drug reactions
-
Levy M. Role of viral infections in the induction of adverse drug reactions. Drug Saf 16 (1997) 1-8
-
(1997)
Drug Saf
, vol.16
, pp. 1-8
-
-
Levy, M.1
-
15
-
-
20444467357
-
Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammatory states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology
-
Prandota J. Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammatory states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology. Am J Ther 12 (2005) 254-261
-
(2005)
Am J Ther
, vol.12
, pp. 254-261
-
-
Prandota, J.1
-
16
-
-
2142645901
-
Are patients with elevated liver tests at increased risk of drug-induced liver injury?
-
Russo M.W., and Watkins P.B. Are patients with elevated liver tests at increased risk of drug-induced liver injury?. Gastroenterology 126 (2004) 1477-1480
-
(2004)
Gastroenterology
, vol.126
, pp. 1477-1480
-
-
Russo, M.W.1
Watkins, P.B.2
-
17
-
-
33845411261
-
Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity
-
Chang T.K.H., and Abbott F.S. Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity. Drug Metab Rev 38 (2006) 627-639
-
(2006)
Drug Metab Rev
, vol.38
, pp. 627-639
-
-
Chang, T.K.H.1
Abbott, F.S.2
-
18
-
-
33947204690
-
Mitochondrial abnormalities-a link to idiosyncratic drug hepatotoxicity?
-
Boelsterli U.A., and Lim P.L.K. Mitochondrial abnormalities-a link to idiosyncratic drug hepatotoxicity?. Toxicol App Pharm 220 (2007) 92-107
-
(2007)
Toxicol App Pharm
, vol.220
, pp. 92-107
-
-
Boelsterli, U.A.1
Lim, P.L.K.2
-
19
-
-
2542539732
-
Tamoxifen induced hepatotoxicity in breast cancer patients with pre-existing liver steatosis: the role of glucose intolerance
-
Elefsiniotis I.S., Pantazis K.D., Ilias A., et al. Tamoxifen induced hepatotoxicity in breast cancer patients with pre-existing liver steatosis: the role of glucose intolerance. Eur J Gastroenterol Hepatol 16 (2004) 593-598
-
(2004)
Eur J Gastroenterol Hepatol
, vol.16
, pp. 593-598
-
-
Elefsiniotis, I.S.1
Pantazis, K.D.2
Ilias, A.3
-
20
-
-
35748961968
-
The role of hepatitis E virus testing in drug-induced liver injury
-
Dalton H.R., Fellows H.J., Stableforth W., et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 26 (2007) 1429-1435
-
(2007)
Aliment Pharmacol Ther
, vol.26
, pp. 1429-1435
-
-
Dalton, H.R.1
Fellows, H.J.2
Stableforth, W.3
-
21
-
-
0038699572
-
Hepatitis E virus epidemiology in industrialized countries
-
Clemente-Casares P., Pina S., Jardi R., et al. Hepatitis E virus epidemiology in industrialized countries. Emerg Inf Dis 9 (2003) 448-454
-
(2003)
Emerg Inf Dis
, vol.9
, pp. 448-454
-
-
Clemente-Casares, P.1
Pina, S.2
Jardi, R.3
-
22
-
-
33845953191
-
The 2006 Bernard B. Brodie award lecture: CYP2E1
-
Gonzalez F.J. The 2006 Bernard B. Brodie award lecture: CYP2E1. Drug Metab Disp 35 (2007) 1-8
-
(2007)
Drug Metab Disp
, vol.35
, pp. 1-8
-
-
Gonzalez, F.J.1
|